Cutaneous sarcoidosis therapy updated.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 17190623.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The widely accepted standard therapy for cutaneous sarcoidosis includes corticosteroids, antimalarials, and methotrexate. However, a better understanding of the basic immunopathogenic properties of sarcoidosis has elucidated a number of steps critical to the persistence and progression of disease that may be vulnerable to treatment by targeted therapy. This article reviews both standard and newer therapeutic options for cutaneous sarcoidosis.
Medical subject headings
- Anti-Inflammatory Agents
- Dermatologic Agents
- Immunosuppressive Agents
- Sarcoidosis
- Skin Diseases